Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Doctor measuring patient's blood pressure | Image credit: Andrey Popov – stock.adobe.com
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes

November 19th 2024

Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.

Young man frustrated with finances | Image credit: master1305 – stock.adobe.com
Young Adults With Low Incomes Have Higher Diabetes Mortality Risk

November 14th 2024

Diabetes | Image credit: Minerva Studio - stock.adobe.com.jpg
Contributor: The Diabetes Vendor Resource Guide—A Useful Directory for Employers

November 13th 2024

AJMC Q&A with Dr Sanjula Jain | Background image credit: ipopba – stock.adobe.com
Rethinking Diabetes Care: Are New Therapies Adding Value or Cost?

November 5th 2024

Aerial shot of neighborhood | Image credit: trekandphoto – stock.adobe.com
How Neighborhood Social Needs Drive Diabetes Care Disparities

October 18th 2024

More News

Insulin syringes
November 14th 2022

In-State Insulin Manufacturing Will Benefit Californians With Diabetes, Commentary States

Julia Bonavitacola
Producing insulin in state could help to lower the price for California residents with diabetes in the 3 years following implementation of the CalRx initiative.
Site Logo
November 11th 2022

Type 2 Diabetes Patient Activation and mHealth Interventions Decreased Cardiovascular Disease Risk

Adesuwa Olomu, MD, MS Richa Tikaria, MD Karen Kelly-Blake, PhD William Hart-Davidson, PhD Ling Wang, PhD Zane Alroshood, BSc Azazaiah Israel, BSc Margaret Holmes-Rovner, PhD
Mobile health (mHealth) and a patient activation program could serve as a model for improving health outcomes for patients in outpatient clinical settings by decreasing atherosclerotic cardiovascular disease risk score.
Kidneys
November 9th 2022

Long-term Use of Empagliflozin, SGLT2 Inhibition Associated With Mitigation of Kidney Function Loss

Julia Bonavitacola
Patients with type 2 diabetes who use empagliflozin or sodium-glucose cotransporter 2 (SGLT2) inhibitors (SGLT2) long term were shown to have less kidney function loss.
Graphic of blood sugar level and artery
November 4th 2022

Fibrosis-4 Associated With Arterial Damage, CHD Risk in Patients With T2D

Julia Bonavitacola
A cross-sectional study found that fibrosis-4 index was linked to arterial damage and risk of coronary heart disease (CHD) in people with type 2 diabetes (T2D).
Site Logo
November 3rd 2022

Impact of Food Affordability on Diabetes-Related Preventable Hospitalization

Sujith Ramachandran, PhD Yiqiao Zhang, MS Tyler J. Dunn, PhD Swarnali Goswami, MS Eric Pittman, PharmD Georgianna Mann, PhD Annie Cafer, PhD
Medicaid enrollees residing in counties with greater food affordability had lower odds of preventable hospitalization related to diabetes.
Scale and tape measure
November 1st 2022

Diabetic Kidney Disease Progression Associated With Changes in Muscle, Fat Amounts

Julia Bonavitacola
Patients with type 2 diabetes with a high to very high prognostic risk of diabetic kidney disease were more likely to have a reduced rectus femoris cross-sectional area, a measure of muscle mass in the lower body, and an increased visceral fat area.
Jug of milk
October 24th 2022

Dairy Consumption Inversely Associated With Diabetes Risk

Julia Bonavitacola
A recent study found that participants who consumed dairy had a lower risk of receiving a diabetes diagnosis compared with those who did not eat dairy and those who ate too much dairy.
What We're Reading
October 18th 2022

What We’re Reading: COVID-19 Rise in Europe; FDA Meeting on Pregnancy Drug; Insulin Costs Lead to Rations

AJMC Staff
Experts anticipate a rise in US COVID-19 cases, hospitalizations, and deaths beginning in 3 to 4 weeks; Covis Pharma pushes to keep hydroxyprogesterone caproate (Makena) on the market; more than 1.3 million American adults with diabetes delayed purchasing or skipped or rationed insulin doses due to high costs.
Older woman receiving blood sugar test
October 13th 2022

Age at Diagnosis of Diabetes Associated With Different Adverse Outcomes

Julia Bonavitacola
A cohort study found that patients diagnosed with diabetes at a younger age were more at risk for adverse outcomes when compared with later diagnosis.
Site Logo
October 12th 2022

Long-term Medication Adherence and Preventive vs Reactive Care Utilization Among Older Adults With Diabetes

Aliza R. Karpes Matusevich, PhD Christy Xavier, PharmD Rafia S. Rasu, PhD
This study using Medical Expenditure Panel Survey data found greater health care utilization and expenditure among adults 65 years and older who were adherent to oral hypoglycemic agents.
Image of an older patient
October 11th 2022

Older Adults With Diabetes Have Higher Prevalence of Depressive Symptoms

Julia Bonavitacola
This new study investigated the prevalence of and health factors that are associated with depressive symptoms in older adults with diabetes.
Psychological Resilience Associated With Better Physical Function, QOL in Patients With Type 2 Diabetes
October 7th 2022

Psychological Resilience Associated With Better Physical Function, QOL in Patients With Type 2 Diabetes

Julia Bonavitacola
A study found that older adults with type 2 diabetes had better physical function and quality of life (QOL) if they had higher psychological resilience.
Woman sitting alone on couch
October 5th 2022

Loneliness Associated With Increased Risk of Type 2 Diabetes

Julia Bonavitacola
Loneliness may be a factor that increases the risk of type 2 diabetes but is not mediated by depression or insomnia, according to new study findings.
What We're Reading
September 22nd 2022

What We’re Reading: Fewer Uninsured Children; Updated Pediatric COVID-19 Vaccines; Two Diabetes Drugs Performed Best in Study

AJMC Staff
About 200,000 more children have health insurance since the start of the COVID-19 pandemic; if FDA-approved, bivalent COVID-19 vaccines for younger children are expected to become available by early to mid-October; a trial compared metformin plus sitagliptin, liraglutide, glimepiride, and insulin glargine for maintaining blood glucose levels.
Picture of fruit with tape measure and hand weight
September 21st 2022

Preservatives, Dietary Elements Identified as Contributors to Obesity, Type 2 Diabetes

Julia Bonavitacola
Evidence points to flavorings and preservatives in processed foods as contributors to the beginnings of obesity and type 2 diabetes, according to a recent review.
Site Logo
September 15th 2022

Part I: The Promise of Telehealth – A Cautionary Tale

Neil Minkoff, MD Joshua Greenblatt, BFA Yana Volman, MBA
The rise of telehealth during COVID-19, its limitations, and its uncertain future.
Older adult sitting on a couch
September 15th 2022

Executive Function Associated With Quality of Life, Negative Emotion in Older Adults With Diabetes

Julia Bonavitacola
A longitudinal study found that executive function was more predictive than pain for present and future quality of life in older adults with diabetes.
Site Logo
September 14th 2022

Pharmaceutical Care Services for Patients With Diabetes: A Systematic Scoping Review

Ramzi Shawahna, PhD Farah Thawabi, PharmD Rahaf Salah, PharmD Sally Ramadan, PharmD
Major databases were systematically searched for articles reporting on pharmaceutical care services for patients with diabetes, and 86 pharmaceutical care services were qualitatively synthesized.
Link Between T2D Complications, Sleep Disorders Found in Mexican Americans
September 12th 2022

Link Between T2D Complications, Sleep Disorders Found in Mexican Americans

Julia Bonavitacola
A recent study found a potential relationship between type 2 diabetes (T2D) macro- and microvascular complications and increased risk of sleep disorders in older Mexican Americans.
City
September 10th 2022

Diabetes-Related Mortality Rates Decrease in Urban Areas, Remain Stagnant in Rural

Julia Bonavitacola
A new study has found that diabetes-related deaths in rural areas did not decrease for the period of 1999 to 2019, tripling the mortality gap between urban and rural patients with diabetes.
Vegetables, fish, and chicken
September 6th 2022

Reduced Processed Red Meat Consumption May Lower Diabetes Risk

Julia Bonavitacola
A prospective cohort study found that women who replaced processed red meat with fatty fish, unprocessed red meat, or vegetables had reduced risks of hypertension and diabetes.
Two people walking
August 31st 2022

People Who Accumulate More Steps per Day Have Lower Risk of Diabetes

Julia Bonavitacola
A population-based cohort study of Hispanic Americans found that people who walked more per day had a lower risk of being diagnosed with type 2 diabetes.
image of woman in CBT session
August 29th 2022

Review Examines Traditional, Newer Forms of CBT on Diabetes-Related Distress

Allison Inserro
While cognitive behavioral therapy (CBT) is known to be effective for generalized depression and anxiety, it is only recently that research has begun exploring its specific use in diabetes, including looking at the effects on depression, anxiety, and glycemic control.
What We're Reading
August 25th 2022

What We’re Reading: Amazon Care to Shut Down; Rise in Youth T2D Diagnoses; Revealing Pressure on FDA Authorization Decisions

AJMC Staff
Amazon will shut down its telehealth venture Amazon Care by the end of 2022; youth type 2 diabetes (T2D) diagnoses rose by 77% in the first year of the COVID-19 pandemic; officials during Donald Trump’s presidency tried to push for the FDA reauthorization of a discredited COVID-19 treatment.
Insulin
August 24th 2022

Self-management Vital for Patients With Diabetes Who Have Intellectual Disabilities

Julia Bonavitacola
According to this systematic review, the best way to optimize diabetes management for patients with both diabetes and intellectual disabilities is supported self-management, which has numerous obstacles to full implementation.
graphic depicting health care costs
August 21st 2022

Health Care Utilization Study Compares Costs of Empagliflozin, DPP-4 Inhibitors, and GLP-1 Agonists for T2D

Rose McNulty
The results suggest that dipeptidyl peptidase-4 (DDP-4) inhibitors, which are widely prescribed in Germany, are not a cost-effective option despite lower drug pricing compared with empagliflozin.
Blood cells
August 14th 2022

Biomarker Linked With Risk of Diabetes, Cancer Deaths

Julia Bonavitacola
A cross-sectional association was found between plasma prostasin level and risk of diabetes and cancer mortality in patients with high blood glucose levels.
Paul Hahn, MD
August 12th 2022

Dr Paul Hahn on the Importance of Understanding the Economic Value of DME Treatments

For vision-threatening diseases, such as diabetic macular edema (DME) understanding the economic value of treatments can help identify the direct and indirect benefits of different treatments, said Paul Hahn, MD, vitreoretinal surgeon at NJRetina.
Site Logo
August 9th 2022

Activation, Physical Activity, and Outcomes Among Individuals With T2D

Radhika Nair, PhD Eric Meadows, PhD Richard Sheer, BA Ilya Lipkovich, PhD Jiat-Ling Poon, PhD Zhenxiang Zhao, PhD Brian Benneyworth, MD Margaret Pasquale, PhD
This study presents an integrated, exploratory assessment of physical activity, patient activation, health-related quality of life, and clinical outcomes among older adults with type 2 diabetes (T2D) using survey, wellness, and claims data.
capsule bursting open with change
August 8th 2022

Budget Bill Allowing Medicare to Negotiate Drug Prices Heads to House

Allison Inserro
HR 5376, or the Inflation Reduction Act, is most significant piece of legislation affecting federal health policy since the passage of the Affordable Care Act in 2010; for Medicare beneficiaries, it caps insulin at $35 a month and includes other pricing reforms.
<12345678910
...
97>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo